Vascular intervention specialist OrbusNeich Medical Group Limited, a Wholly Owned Foreign Enterprise (WOFE) based in Shenzhen, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange (HKSE). Details regarding the pricing and timing of the IPO have yet to be released.
Company Profile
OrbusNeich is a leading manufacturer of PCI/PTA balloons, specializing in the production of interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA). As of June 30, 2022, the company has over 40 approved products, including 25 in Japan, 22 in the European Union, 14 in the US, and 15 in China. OrbusNeich has expanded its business footprint to cover structural cardiac intervention, neural intervention, and other fields.
Financial Performance
OrbusNeich generated USD 116 million in revenues in 2021 and USD 68.85 million in the first half of 2022. The company’s strong financial performance underscores its position as a key player in the global vascular intervention market.-Fineline Info & Tech
